DGAP-News: Mayo Clinic Selects Complete Genomics to Provide Outsourced Whole Genome Sequencing
(businesspress24) - Complete Genomics
13.02.2012 14:00
---------------------------------------------------------------------------
MOUNTAIN VIEW, Calif., 2012-02-13 14:00 CET (GLOBE NEWSWIRE) --
Complete Genomics Inc. (Nasdaq:GNOM) announced today that it has been selected
by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole
human genome sequencing. Mayo Clinic researchers will now be able to employ
Complete Genomics' sequencing service for some of its large-scale whole genome
sequencing projects.
The Center for Individualized Medicine operates a comprehensive sequencing
laboratory in its own Medical Genome Facility, but it determined that
collaboration with Complete Genomics could supplement the services available to
its community of medical researchers. Under the terms of the agreement, Mayo
Clinic can send genetic material to Complete Genomics for sequencing and
analysis. It will continue to operate and invest in its Medical Genome
Facility. Financial details of the agreement were not disclosed.
'Mayo Clinic, through the Center for Individualized Medicine, already has
several high-impact genome- and epigenome-based studies underway in
individualized care for our patients,' said Gianrico Farrugia, M.D., director
of Mayo Clinic's Center for Individualized Medicine. 'Access to quality whole
genome sequencing services can only expedite our efforts to improve care for
all of our patients with new individualized medicine tools and techniques.'
'It is exciting to see a world-renowned healthcare organization like Mayo
Clinic take the next step towards bringing high-quality whole genome sequencing
data into the clinic. They clearly recognize its potential to personalize
treatment options and improve the future quality of patient care,' said Leroy
Hood, M.D., Ph.D., president of the Institute for Systems Biology and a member
of Complete Genomics' Scientific Advisory Board. 'This is a big step toward the
realization of personalized medicine.'
'For well over a century, Mayo Clinic has been an innovator and leader in
translating cutting-edge clinical research into world-class patient care and
treatment,' said Clifford Reid, Ph.D., chairman, president and CEO of Complete
Genomics. 'We are honored to be partnering with Mayo Clinic researchers to
provide sequencing and analysis for their genomic studies and investigations.'
Projects will be coordinated with the Center of Individualized Medicine's
Medical Genome Facility and will help expedite Mayo Clinic's translational
genomics-based programs. Through these initiatives, Mayo Clinic will develop
best practices for using genetic information to guide patient care.
Mayo's effort is part of a growing trend in medicine to collect and analyze the
genetic information from consenting patients to optimize medical care in a
variety of disciplines, including cancer diagnosis and treatment, drug therapy,
disease prevention, and many others. This information could also be used by
doctors to advise patients about lifestyle changes that could help prevent or
delay disease onset.
About The Center for Individualized Medicine
The Center for Individualized Medicine discovers and integrates the latest in
genomic, molecular and clinical sciences into personalized care for each Mayo
Clinic patient.
http://mayoresearch.mayo.edu/center-for-individualized-medicine/
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and
education for people from all walks of life. For more information, visit
MayoClinic.com or MayoClinic.org/news.
About Complete Genomics
Complete Genomics is the whole human genome sequencing company that has
developed and commercialized an innovative DNA sequencing service. The Complete
Genomics Analysis Platform (CGA(tm) Platform) combines Complete Genomics'
proprietary human genome sequencing technology with advanced informatics and
data management software. Additional information can be found at
http://www.completegenomics.com.
The Complete Genomics logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8216
CONTACT: Complete Genomics
Jennifer Turcotte
Vice President of Marketing
(650) 943-2846
jturcotte(at)completegenomics.com
Waggener Edstrom Worldwide Healthcare
Lisa Osborne
Account Director
(202) 261-7806
lisao(at)waggeneredstrom.com
News Source: NASDAQ OMX
13.02.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Complete Genomics
United States
Phone:
Fax:
E-mail:
Internet:
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.02.2012 - 08:00 Uhr
Sprache: Deutsch
News-ID 573118
Anzahl Zeichen: 0
Kontakt-Informationen:
Ansprechpartner:
Stadt:
Telefon:
Kategorie:
Wirtschaft (allg.)
Anmerkungen:
Diese Pressemitteilung wurde bisher 134 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Mayo Clinic Selects Complete Genomics to Provide Outsourced Whole Genome Sequencing
"
steht unter der journalistisch-redaktionellen Verantwortung von
Complete Genomics (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
